Comparing injection and non-injection routes of administration for heroin, methamphetamine, and cocaine users in the United States

Journal of Addictive Diseases

Volumn 30, Issue 3, 2011, Pages 248-257

  Novak, Scott P ^a   Kral, Alex H ^a  

^a RTI INTERNATIONAL   (United States)

Author keywords

cocaine; epidemiology; heroin; Injection drug use; methamphetamine; routes of administration

Indexed keywords

COCAINE; DIAMORPHINE; ILLICIT DRUG; METHAMPHETAMINE;

ADOLESCENT; ADULT; ARTICLE; CHILD; COCAINE DEPENDENCE; COMPARATIVE STUDY; DEMOGRAPHY; DRUG ABUSE; DRUG DEPENDENCE; FEMALE; HEALTH SURVEY; HEROIN DEPENDENCE; HUMAN; INJECTION; INTRAVENOUS DRUG ABUSE; MAJOR CLINICAL STUDY; MAJOR DEPRESSION; MALE; SCHOOL CHILD; SUBSTANCE ABUSE; UNITED STATES;

ADOLESCENT; ADULT; BEHAVIOR, ADDICTIVE; CHILD; COCAINE; CROSS-SECTIONAL STUDIES; DEMOGRAPHY; DRUG ADMINISTRATION ROUTES; DRUG USERS; FEMALE; HEALTH SURVEYS; HEROIN; HUMANS; MALE; METHAMPHETAMINE; UNITED STATES;

EID: 79960689552     PISSN: 10550887     EISSN: 15450848     Source Type: Journal    
DOI: 10.1080/10550887.2011.581989     Document Type: Article

References (36)

1. Kandel DB, Yamaguchi K, Klein LC. Testing the gateway hypothesis. Addiction 2006; 101:470-2. (Pubitemid 43375608)
2. McLellan AT, Lewis DC, OBrien CP, Kleber HD. Drug dependence, a chronic medical illness: implications for treatment, insurance, and outcomes evaluation. JAMA 2000; 284:1689-95.
3. Vega WA, Aguilar-Gaxiola S, Andrade L, et al. Prevalence and age of onset for drug use in seven international sites: results from the international consortium of psychiatric epidemiology. Drug Alcohol Depend 2002; 68:285-97. (Pubitemid 35232564)
4. McKim W. Drugs and behavior: an overview of behavioral pharmacology. Upper Saddle River, NJ: Prentice Hall, 2000.
5. Ducharme LJ, Knudsen HK, Roman PM. Evidencebased treatment for opiate-dependent clients: availability, variation, and organizational correlates.AmJDrugAlcohol Abuse 2006; 32:569-76. (Pubitemid 44870995)
6. Geppert C, Bogenschutz MP. Pharmacological research on addictions: a framework for ethical and policy considerations. J Psychoactive Drugs 2009; 41:49-60.
7. Grella CE. From generic to gender-responsive treatment: changes in social policies, treatment services, and outcomes of women in substance abuse treatment. J Psychoactive Drugs 2008; Suppl 5:327-43.
8. Schnabel J. Neuroscience: rethinking rehab. Nature 2009; 458(7234):25-7.
9. Des Jarlais DC, Diaz T, Perlis T, et al. Variability in the incidence of human immunodeficiency virus, hepatitis B virus, and hepatitis C virus infection among young injecting drug users in New York City. AmJ Epidemiol 2003; 157:467-71. (Pubitemid 36258602)
10. Kral AH, Bluthenthal RN, Erringer EA, Lorvick J, Edlin BR. Risk factors among IDUs who give injections to or receive injections from other drug users. Addiction 1999; 94:675-83. (Pubitemid 29229480)
11. Thomas DL, Shih JW, Alter HJ, et al. Effect of human immunodeficiency virus on hepatitis C virus infection among injecting drug users. J Infect Dis 1996; 174:690-5. (Pubitemid 26325882)
12. Sterrett C, Brownfield J, Korn CS, Hollinger M, Henderson SO. Patterns of presentation in heroin overdose resulting in pulmonary edema. Am J Emerg Med 2003; 21:32-4. (Pubitemid 36176127)
13. Warner-Smith M, Darke S, Day C. Morbidity associated with non-fatal heroin overdose. Addiction 2002; 97:963-7.
14. AmodeoM, Lundgren L, Chassler D,Witas J. Highfrequency users of detoxification: who are they? Subst Use Misuse 2008; 43:839-49. (Pubitemid 351892447)
15. Chassler D, Lundgren L, Lonsdale J. What factors are associated with high-frequency drug treatment use among a racially and ethnically diverse population of injection drug users? Am J Addict 2006; 15:440-9. (Pubitemid 46018040)
16. Substance Abuse and Mental Health Services Administration, Office of Applied Studies. Treatment Episode Data Set (TEDS). Highlights - 2007. National Admissions to Substance Abuse Treatment Services, DASIS Series: S-45, DHHS Publication No. (SMA) 09-4360, Rockville, MD, 2009. Available from:
17. Vann RE, Wise LE, Varvel SA, Philibin SD, Walentiny DM, Porter JH. Route of administration influences substitution patterns in rats trained to discriminate methadone vs. vehicle. Drug Alcohol Depend 2009; 103(3):124-30.
18. Porrino LJ. Functional consequences of acute cocaine treatment depend on route of administration. Psychopharmacology (Berl) 1993; 112(2-3):343-51. (Pubitemid 23278299)
19. Barrio G, De La Fuente L, Lew C, Royuela L, Bravo MJ, Torrens M. Differences in severity of heroin dependence by route of administration: the importance of length of heroin use. Drug Alcohol Depend 2001; 63:169-77. (Pubitemid 32488931)
20. Gossop M, Marsden J, Stewart D, Treacy S. Routes of drug administration and multiple drug misuse: regional variations among clients seeking treatment at programmes throughout England. Addiction 2000; 95:1197-206. (Pubitemid 30644105)
21. Substance Abuse and Mental Health Services Administration, Office of Applied Studies. Results from the 2007 National Survey on Drug Use and Health: National Findings (NSDUH Series H-34, DHHS Publication No. SMA 08-4343). Rockville, MD, 2008.
22. American Psychiatric Association. Diagnostic and statistical manual of mental disorders (4th ed.). Washington, DC: Author, 2000.
23. SAMHSA. Center for Substance Abuse Treatment Treatment Improvement Protocal Series. Available from: http://tie.samhsa.gov/externals/tips.html [Accessed: July 21 2009]
24. Cohen J. Statistical power analysis for the behavioral sciences (2nd edition). Hillsdale, NJ: Erlbaum, 1988.
25. RTI. SUDAAN Users manual, release 10.0. Research Triangle Park, NC: RTI International, 2009.
26. McLellan AT, McKay JR, Forman R, Cacciola J, Kemp J. Reconsidering the evaluation of addiction treatment: from retrospective follow-up to concurrent recovery monitoring. Addiction 2005; 100:447-58. (Pubitemid 40529837)
27. Lau AS. Making the case for selective and directed cultural adaptations of evidence-based treatments. Clin Psych: Sci and Practice 2006; 13:295-310. (Pubitemid 46729762)
28. Fareed A, Vayalapalli S, Casarella J, Amar R, Drexler K. Heroin anticraving medications: a systematic review. Am J Drug Alcohol Abuse 2010; 36:332-41.
29. Shoptaw S, Rawson RA, McCann MJ, Obert JL. The Matrix model of outpatient stimulant abuse treatment: evidence of efficacy. J Addict Dis 1994; l13:129-41.
30. NIDA. Principles of drug addiction treatment: a research based guide. Rockville, MD: NIH, 1999.
31. Bluthenthal RN. Syringe exchange as a socialmovement: a case study of harm reduction in Oakland, California. Subst Use Misuse 1998; 33:1147-71. (Pubitemid 28237011)
32. Latkin CA, Knowlton AR, Sherman S. Routes of drug administration, differential affiliation, and lifestyle stability among cocaine and opiate users: implications to HIV prevention. J Subst Abuse 2001; 13(1-2):89-102. (Pubitemid 38209963)
33. Ciccarone D, Bamberger JD, Kral AH, et al. Soft tissue infections among injection drug users-San Francisco, California, 1996-2000; MMWR 2001; 50:381-4.
34. Ciccarone D, Bourgois P. Explaining the geographical variation of HIV among injection drug users in the United States. Subst Use Misuse 2003; 38:2049-63. (Pubitemid 37499738)
35. Brady JE, Friedman SR, Cooper HL, Flom PL, Tempalski B, Gostnell K. Estimating the prevalence of injection drug users in the U.S. and in large U.S. metropolitan areas from 1992 to 2002. J Urban Health 2008; 85:323-51.
36. Simpson DD, Brown B. (Eds.). Special issue on treatment process and outcome studies from DATOS. Drug and Alcohol Dependence 1999 December; 57(2).